Cite
New Data from University of California Illuminate Research in Squamous Cell Carcinoma (Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma).
MLA
“New Data from University of California Illuminate Research in Squamous Cell Carcinoma (Histone-Methyltransferase KMT2D Deficiency Impairs the Fanconi Anemia/BRCA Pathway upon Glycolytic Inhibition in Squamous Cell Carcinoma).” Hematology Week, Aug. 2024, p. 252. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=179224684&authtype=sso&custid=ns315887.
APA
New Data from University of California Illuminate Research in Squamous Cell Carcinoma (Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma). (2024). Hematology Week, 252.
Chicago
“New Data from University of California Illuminate Research in Squamous Cell Carcinoma (Histone-Methyltransferase KMT2D Deficiency Impairs the Fanconi Anemia/BRCA Pathway upon Glycolytic Inhibition in Squamous Cell Carcinoma).” 2024. Hematology Week, August, 252. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=179224684&authtype=sso&custid=ns315887.